Intellia Therapeutics Inc (NASDAQ:NTLA)
| 48.27 Delayed Data As of 3:59pm ET |  -1.41 / -2.84%Today’s Change | 37.08 Today|||52-Week Range 130.33 | -59.18% Year-to-Date |
Latest NTLA News | Press Releases
No recent news for Intellia Therapeutics Inc.
Today’s Trading
| Previous close | 49.68 |
| Today’s open | 49.85 |
| Day’s range | 47.80 - 50.64 |
| Volume | 25,777 |
| Average volume (3 months) | 1,040,352 |
| Market cap | $3.9B |
Data as of 3:59pm ET, 11/28/2022
Growth & Valuation
| Earnings growth (last year) | -57.61% |
| Earnings growth (this year) | -62.23% |
| Earnings growth (next 5 years) | +13.22% |
| Revenue growth (last year) | -43.01% |
| P/E ratio | NM |
| Price/Sales | 253.61 |
| Price/Book | 3.55 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DNLIDenali Therapeutics ... | -1.12 | -3.74% |
| CRSPCRISPR Therapeutics ... | -1.63 | -2.96% |
| ---- | ||
| ARWRArrowhead Pharmaceut... | -0.89 | -3.02% |
Data as of 4:00pm ET, 11/28/2022
Financials
| Next reporting date | March 15, 2023 |
| EPS forecast (this quarter) | -$1.37 |
| Annual revenue (last year) | $33.1M |
| Annual profit (last year) | -$267.9M |
| Net profit margin | -810.49% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
